Vanguard Global Advisers
GLSI icon

Vanguard Global Advisers’s Greenwich LifeSciences GLSI Stock Holding History

Vanguard Global Advisers’s Portfolio GLSI Stock Details GLSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$278K Buy
11,871
+1,536
+15% +$37.4K ﹤0.01% 2365
2026
Q1 		$248K Buy
+10,335
New +$270K ﹤0.01% 2333

Other funds holding GLSI

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Vanguard Global Advisers's GLSI Position: Q2 2026 in Review

Vanguard Global Advisers increased its Greenwich LifeSciences (GLSI) stake by 15% in Q2 2026, buying an estimated $37.4K and bringing the position to 11,871 shares worth $278K. The position accounts for ﹤0.01% of the portfolio, ranked #2365.

Vanguard Global Advisers first reported a position in GLSI in Q1 2026 and has held it in 2 quarters since. 58 funds tracked by Wall St. Rank hold GLSI as of Q2 2026.

  • Vanguard Global Advisers held 11,871 shares of Greenwich LifeSciences worth $278K as of Q2 2026.
  • Vanguard Global Advisers bought 1,536 Greenwich LifeSciences shares in Q2 2026, an estimated $37.4K.
  • Greenwich LifeSciences made up ﹤0.01% of Vanguard Global Advisers's portfolio in Q2 2026, its #2365 holding.
  • Vanguard Global Advisers first reported a position in Greenwich LifeSciences in Q1 2026 and has held it in 2 quarters since.
  • 58 funds tracked by Wall St. Rank held Greenwich LifeSciences as of Q2 2026.

Based on Vanguard Global Advisers's 13F filing for Q2 2026, filed 13 Aug 2026.